All Events

Upcoming Events

DCAT Week ‘18

DCAT Week ‘18

Conference

DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit,...

View

Archives

8th Annual Clinical Quality Oversight Forum

8th Annual Clinical Quality Oversight Forum

Conference

Join 150+ senior-level clinical quality, compliance and operations professionals from pharma, biotech and device companies, to discuss strategies for ensuring clinical trial integrity by optimizing and managing the quality of vendors and sites.

View

DIA 2017 Annual Meeting

DIA 2017 Annual Meeting

Conference & exhibition

The DIA Global Annual Meeting is the largest, longest-running event in the life sciences industry to foster the international exchange of actionable insights to improve health through the advancement of lifesaving medicines and technologies. 

View

2nd Annual Pharmaceutical Congress China

2nd Annual Pharmaceutical Congress China

Conference

This 2017, the 2nd Annual Pharmaceutical Congress China, part of IBC’s PharmaCon Series will co-locate 3 events: Pharmaceutical Compliance, Patient-Centric Clinical Trials, and Clinical Trials Site Selection & Quality.

View

INTERPHEX

INTERPHEX

Conference

All of the Solutions you need to Cost Effectively Develop and Manufacture Quality Product. INTERPHEX is THE pharma, bio and device development/manufacturing event to “Experience Science through Commercialization”. 

View

Excipients Innovations 2015

Excipients Innovations 2015

Online Event

This event will examine the drug excipients market, from the historical events that have defined the sector to the debates going on at the moment to predictions about the demands that will drive it in the future.How did the DEG tragedies of the last century...

View

Bioavailability Challenge 2014

Bioavailability Challenge 2014

Online Event

It is a well-established principal that even the most promising API, monoclonal antibody or therapeutic peptide can only be turned into an effective and marketable drug if formulated in such a way that it reaches the blood stream and is bioavailable.But,...

View

BAC14

Bioavailability market dynamics

Webinar

How healthy is demand for bioavailability enhancement services? Is the growth of the generics sector driving the market or do innovative pharma firms determine the type of solubility solutions that are available.When biopharmaceutical are injected they...

View

A brief history of bioavailability

A brief history of bioavailability

Webinar

Tablets have been around for almost 200 years. In this presentation we trace the history of their development, from the accidental invention of the sustained release pill through to the latest breakthroughs in bioavailability enhancement, this talk will...

View

From the lab to the factory

From the lab to the factory

Online Event

How do you take a successful bioavailability solution from the laboratory to the pilot plant and on to commercial-scale production? What are the potential pitfalls and considerations involved in successfully scaling-up the production of a poorly soluble...

View

Shaping amorphous solid dispersion

Shaping amorphous solid dispersion

Online Event

Creating an Amorphous Solid Dispersion (ASD) is an increasingly popular way of improving Active Pharmaceutical Ingredient (API) solubility. But while the approach can be successful, the big problem is demonstrating ASD stability, preventing ingredients...

View

Oncology Trials Outsourcing 2011

Oncology Trials Outsourcing 2011

Online Event

Cancer drug development is the most complex challenge faced by the drug industry today, with clinical trials being the most technically difficult, time consuming and expensive aspect of the process. 
Recruiting patients, monitoring sites and...

View

State of the market

State of the market

Forum

On average over half the cost of developing a new cancer drug is associated with work outsourced to contract research organisations (CRO), according to analysis by Cutting Edge Information. This finding, coupled with the pharmaceutical industry’s ever...

View

Patient recruitment: improving access to patients

Patient recruitment: improving access to patients

Forum

Recruiting patients is often, if not always, the most expensive and time consuming part of a clinical trial. For oncology drug development the problem is particularly pronouncedThis presentation will focus on new techniques to improve access to the right...

View

Managing strategic relationships in cancer trials

Managing strategic relationships in cancer trials

Forum

The way drug companies work with CROs is evolving, with the emphasis shifting from the client-service provider model to a more strategic, long-term relationship focused approach.This presentation will discuss the role strategic partnerships can play in...

View